Related Experiment Videos
Prostatic origin of tumors. An immunohistochemical study
American Journal of Clinical Pathology
|June 1, 1980
Summary
Prostatic acid phosphatase (PAP) can be detected using immunoperoxidase staining to identify the origin of prostate cancer. This method accurately distinguishes prostate tumors from other cancers, aiding in diagnosis.
Area of Science:
- Oncology
- Pathology
- Immunohistochemistry
Background:
- Prostate cancer diagnosis and staging can be challenging, especially with metastatic disease.
- Identifying the primary origin of neoplasms is crucial for effective treatment planning.
Purpose of the Study:
- To investigate the utility of prostatic acid phosphatase (PAP) detection in diagnosing primary and metastatic prostate neoplasms.
- To explore the histogenesis of prostate tumors and confirm prostatic origin of metastases using immunohistochemistry.
Main Methods:
- Immunoperoxidase technique utilizing a specific antiserum to PAP.
- Application of the peroxidase-antiperoxidase (PAP) procedure on formalin-fixed, paraffin-embedded pathology specimens.
- Testing of 37 cases of known prostatic carcinomas and 44 cases of nonprostatic tumors.
Main Results:
- All 37 primary and metastatic prostate carcinoma specimens showed positive staining for PAP.
- None of the 44 nonprostatic tumor specimens stained positive for PAP.
- The immunoperoxidase technique demonstrated high specificity and sensitivity for PAP.
Conclusions:
- Immunoperoxidase detection of PAP is a reliable method for confirming the prostatic origin of neoplasms.
- This technique is valuable for diagnosing unclassifiable primary or metastatic tumors.
- PAP staining offers a practical and specific diagnostic tool in surgical pathology.